IL266840A - History of tyrosine and preparations containing them - Google Patents

History of tyrosine and preparations containing them

Info

Publication number
IL266840A
IL266840A IL266840A IL26684019A IL266840A IL 266840 A IL266840 A IL 266840A IL 266840 A IL266840 A IL 266840A IL 26684019 A IL26684019 A IL 26684019A IL 266840 A IL266840 A IL 266840A
Authority
IL
Israel
Prior art keywords
compositions
tyrosine derivatives
tyrosine
derivatives
Prior art date
Application number
IL266840A
Other languages
English (en)
Hebrew (he)
Original Assignee
Tyme Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US15/365,120 external-priority patent/US20170080093A1/en
Application filed by Tyme Inc filed Critical Tyme Inc
Publication of IL266840A publication Critical patent/IL266840A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL266840A 2016-11-30 2019-05-23 History of tyrosine and preparations containing them IL266840A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15/365,120 US20170080093A1 (en) 2013-10-22 2016-11-30 Tyrosine Derivatives And Compositions Comprising Them
PCT/US2017/063865 WO2018102506A1 (en) 2016-11-30 2017-11-30 Tyrosine derivatives and compositions comprising them

Publications (1)

Publication Number Publication Date
IL266840A true IL266840A (en) 2019-07-31

Family

ID=60703174

Family Applications (1)

Application Number Title Priority Date Filing Date
IL266840A IL266840A (en) 2016-11-30 2019-05-23 History of tyrosine and preparations containing them

Country Status (12)

Country Link
EP (1) EP3548086A1 (https=)
JP (2) JP2019536783A (https=)
KR (1) KR20190089191A (https=)
CN (1) CN110062633A (https=)
AU (1) AU2017368135A1 (https=)
BR (1) BR112019011033A2 (https=)
CA (1) CA3045110A1 (https=)
EA (1) EA201991305A1 (https=)
IL (1) IL266840A (https=)
MX (1) MX2019006326A (https=)
PH (1) PH12019501186A1 (https=)
WO (1) WO2018102506A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111743887A (zh) * 2019-03-26 2020-10-09 深圳先进技术研究院 α-甲基酪氨酸或其衍生物的用途
PH12021552866A1 (en) 2019-05-14 2022-11-07 Tyme Inc Compositions and methods for treating cancer
CN115379851A (zh) * 2019-11-07 2022-11-22 因斯瑞拜奥有限公司 使用生长因子抗体与非酪氨酸靶向激酶抑制剂的组合的方法和组合物
WO2021146506A2 (en) * 2020-01-17 2021-07-22 Tyme, Inc. Compositions and methods for modulating cancer
US10905698B1 (en) 2020-05-14 2021-02-02 Tyme, Inc. Methods of treating SARS-COV-2 infections

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI323662B (en) * 2002-11-15 2010-04-21 Telik Inc Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy
EP3075247B1 (en) * 2004-02-02 2022-10-12 BioSight Ltd. Conjugates for cancer therapy and diagnosis
KR20090014164A (ko) * 2006-04-19 2009-02-06 더 보드 오브 리전츠 오브 더 유니버시티 오브 텍사스 시스템 세포 영상화 및 치료를 위한 조성물 및 방법
EP3050566B1 (en) * 2007-09-10 2018-11-28 Boston Biomedical, Inc. A novel group of stat3 pathway inhibitors and cancer stem cell pathway inhibitors
PL2804599T3 (pl) * 2012-01-17 2019-06-28 Tyme, Inc. Terapia skojarzona do leczenia nowotworu złośliwego
US9585841B2 (en) * 2013-10-22 2017-03-07 Tyme, Inc. Tyrosine derivatives and compositions comprising them

Also Published As

Publication number Publication date
AU2017368135A1 (en) 2019-06-13
KR20190089191A (ko) 2019-07-30
WO2018102506A1 (en) 2018-06-07
CA3045110A1 (en) 2018-06-07
EP3548086A1 (en) 2019-10-09
EA201991305A1 (ru) 2019-10-31
JP2022153587A (ja) 2022-10-12
JP2019536783A (ja) 2019-12-19
PH12019501186A1 (en) 2020-02-10
CN110062633A (zh) 2019-07-26
BR112019011033A2 (pt) 2019-10-15
MX2019006326A (es) 2019-07-12

Similar Documents

Publication Publication Date Title
SI3580561T1 (sl) Metode, osnovane na hla, in njihove sestave ter uporabe
ZA201801511B (en) Flavonoid compositions and methods of use
GB2546350B (en) Compositions and methods
IL271275B1 (en) Preparations containing croons and their uses
GB201807325D0 (en) Compositions and methods
GB201718876D0 (en) Antithrombin-heparin compositions and methods
ZA202104969B (en) Compositions comprising 15-hepe and methods of using the same
GB202201860D0 (en) Novel methods and compositions
GB2564510B (en) Compositions and methods and uses relating thereto
IL266840A (en) History of tyrosine and preparations containing them
GB201502002D0 (en) Uses and compositions
ZA202004533B (en) Skin-brightening compositions and methods
GB201608762D0 (en) Compositions and uses thereof
GB201715820D0 (en) Compositions and methods
GB201705626D0 (en) Compositions and methods
ZA201807665B (en) Methods and compositions
GB201501991D0 (en) Uses and compositions
GB201502026D0 (en) Uses and compositions
GB201512996D0 (en) Compositions and methods
GB201716599D0 (en) Compositions and methods and uses relating thereto
GB201614897D0 (en) Compositions and uses thereof
GB201511886D0 (en) Uses and compositions
GB201812952D0 (en) Compositions and uses thereof
GB201602409D0 (en) Compositions and uses thereof
GB201522814D0 (en) Compositions and uses thereof